Post-Surgical Blood Clot Study Stirs Controversy
A controversial study estimates the risk of venous thromboembolism, or serious blood clot, at 1% for those undergoing knee replacement and .5% for those receiving a new hip during the few days they recuperate in the hospital after surgery.
The authors, Jean-Marie Januel and colleagues from Lausanne University Hospital in Switzerland and co-authors in France and Canada, used data from 47 studies, most of them randomized controlled trials.
They suggest that because VTE is the most frequent surgical adverse event besides infections, their rates might be used for quality analysis and hospital benchmarking Additionally, they write, there is no widely accepted estimate of symptomatic VTE risk prior to hospital discharge that might be "conveyed to patients in the informed consent process."
VTEs, which can result in sudden death, are thought to be largely preventable, especially since one in four VTEs occur in patients who had major surgery such as hip and knee replacements.
All of the patients included received recommended prophylactic medications.
- CVS Ramps Up Retail Clinics with Provider Affiliations
- 4 Tectonic Shifts Shaking Up Healthcare
- Medical Errors Third Leading Cause of Death, Senators Told
- As States Regulate Provider Competition, Common Threads Emerge
- Chronic Disease Care Costs Get Bipartisan Attention
- CareFirst Announces PCMH Program Results
- Mayo Tops U.S. News Best Hospitals Rankings
- Roundtable: Life After a Healthcare Organization Acquisition
- Hospitals Seeking to Understand PPACA Impact Turn to Data
- As HIPAA Breaches Accelerate, Tools Lag